Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3)
Abstract Cromolyn is a known mast cell stabilizer and is approved for treatment of asthma and for other allergic indications. Cromolyn, in a new redesigned dry powder formulation, is being tested in a pivotal clinical trial in combination with low dose ibuprofen to treat early Alzheimer’s Disease (A...
Guardado en:
Autores principales: | Yi-Jun Wang, Alina Monteagudo, Matthew A. Downey, Philip G. Ashton-Rickardt, David R. Elmaleh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12e89e9db6224c8982a7700a49b3f833 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cromolyn platform suppresses fibrosis and inflammation, promotes microglial phagocytosis and neurite outgrowth
por: Yi-Jun Wang, et al.
Publicado: (2021) -
Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans.
por: Zuyi Weng, et al.
Publicado: (2012) -
The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line
por: Mina Baek, et al.
Publicado: (2021) -
Differential Cytokine-Induced Responses of Polarized Microglia
por: Priyanka Chauhan, et al.
Publicado: (2021) -
Application of HMC-SS Method in Pipeline Reliability Analysis and Residual Life Assessment
por: Xin Lin, et al.
Publicado: (2021)